HRMY

Q: What is the price of Harmony Biosciences (HRMY) today?

The price of Harmony Biosciences (HRMY) today is R$ 201,46, with a variation of 2.81% compared to the last year. The price of Harmony Biosciences (HRMY) started the year trading around R$ 186,50 and today it is at R$ 201,46. Follow the real-time price chart, the historical price of Harmony Biosciences (HRMY), and stock data from Ibovespa and international markets.

Q: When does Harmony Biosciences (HRMY) pay dividends?

Harmony Biosciences (HRMY) did not distribute dividends in the last year.

Q: Harmony Biosciences (HRMY) is it worth it?

Currently, Harmony Biosciences (HRMY) is priced at R$ 201,46, with a P/E of 11,93%, representing a deviation of 26,16% from its historical average P/E. In the last year, the stock showed a variation of 2.81% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 2,81%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Harmony Biosciences (HRMY)?

Investing in shares of Harmony Biosciences (HRMY) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Harmony Biosciences (HRMY) yield today?

The yield of Harmony Biosciences (HRMY) was -0,93% in the last month, 2,81% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Harmony Biosciences (HRMY) today, the total investment would be based on the current price of R$ 201,46.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 20.712,25In 5 years: R$ 20.146,14In 10 years: 20.146,14It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Harmony Biosciences Holdings Inc.

Price

US$ 37,17

variation (12m)

2,81%

p/l

11,93

p/vp

2,79

DIVIDEND YIELD

0,00%

quote HRMY

BVMF

HRMY

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of HRMY

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-0,93%

3 months

10,23%

1 year

2,81%

2 years

14,30%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-0,93%

3 months

9,68%

1 year

-2,31%

2 years

4,19%

5 years

0,00%

10 years

0,00%

Indicators HRMY

check out the fundamentals of Harmony Biosciences shares

P/L

11,93

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

2,79

Sector: -3,77 Industry: -3,77

P/VP

2,79

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

16,33%

Sector: -63,50% Industry: -63,50%

ROE

23,40%

Sector: -67,23% Industry: -67,23%

ROIC

34,02%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

23,42%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

78,34%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

28,72%

Sector: -43,21% Industry: -43,21%

P/EBITDA

8,14

Sector: -3,13 Industry: -3,13

P/EBIT

8,95

Sector: -3,41 Industry: -3,41

P/ASSETS

1,95

Sector: 1,29 Industry: 1,29

VPA

13,56

Sector: 1,80 Industry: 1,80

LPA

3,17

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,70

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

37,06%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Harmony Biosciences ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 37,17

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-16,33%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

HRMY indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of HRMY with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history HRMY dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Harmony Biosciences

Harmony Biosciences Holdings Inc.

Average user rating I10

4.0 (8 people)

Estados Unidos

8 years

Foundation: 2017

2020

Year of debut on the stock exchange - 5 years

150

Employees

The Company Harmony Biosciences Holdings Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 2,16 Billions, having a net worth of $ 773,08 Milhões.

With a total of 150 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 772,53 Milhões, which generated a profit in the amount of $ 180,91 Milhões.

As for its main indicators, the Company has a P/E ratio of 11,93, a P/B ratio of 2,79 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker HRMY.

Market value

US$ 2,16 Billions

Net worth

US$ 773,08 Milhões

US$ 773.080.000,00

Assets

US$ 1,11 Billion

US$ 1.108.010.000,00

Total Number of Shares

57,00 Milhões

57.000.000

Average Daily Trading Volume

US$ 606,27 Thousand

US$ 606.267,24

Sector

Cuidados de saúde

Industry

Biotecnologia

HRMY

HRMY revenue and profits

HRMY results

DRAG THE FRAME TO SEE MORE DATA

HRMY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Harmony Biosciences (HRMY) today?

The price of Harmony Biosciences (HRMY) today is R$ 201,46, with a variation of 2.81% compared to the last year. The price of Harmony Biosciences (HRMY) started the year trading around R$ 186,50 and today it is at R$ 201,46. Follow the real-time price chart, the historical price of Harmony Biosciences (HRMY), and stock data from Ibovespa and international markets.

When does Harmony Biosciences (HRMY) pay dividends?

Harmony Biosciences (HRMY) did not distribute dividends in the last year.

Harmony Biosciences (HRMY) is it worth it?

Currently, Harmony Biosciences (HRMY) is priced at R$ 201,46, with a P/E of 11,93%, representing a deviation of 26,16% from its historical average P/E. In the last year, the stock showed a variation of 2.81% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 2,81%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Harmony Biosciences (HRMY)?

Investing in shares of Harmony Biosciences (HRMY) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Harmony Biosciences (HRMY) yield today?

The yield of Harmony Biosciences (HRMY) was -0,93% in the last month, 2,81% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Harmony Biosciences (HRMY) today, the total investment would be based on the current price of R$ 201,46.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 20.712,25
In 5 years: R$ 20.146,14
In 10 years: 20.146,14

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

HRMY

Harmony Biosciences Holdings Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of HRMY

check out the fundamentals of Harmony Biosciences shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Harmony Biosciences

Harmony Biosciences Holdings Inc.

Estados Unidos

8 years

2020

150

PROFIT X PRICE HRMY

HRMY results

HRMY cash flow

evolution of assets - HRMY

HRMY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80